Replies to post #208671 on Biotech Values

[DewDiligence]

FDA approves NVO’s Rebinyn—a long-acting FIX for hemophilia B:

https://globenewswire.com/news-release/2017/05/31/1004785/0/en/Novo-Nordisk-receives-US-FDA-approval-of-REBINYN-nonacog-beta-pegol-N9-GP.html

There are several similar products on the market.

[DewDiligence]

NVO—FDA briefing docs for Semaglutide panel on 10/18/17:

https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm560480.htm